Last $10.77 USD
Change Today -0.16 / -1.46%
Volume 540.0K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 54 RelationshipsChairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Marsha Fanucci 61 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Thomas Koestler Ph.D. 64 RelationshipsDirector, Member of Compensation Committee and Member of Science Committee
Bennett Shapiro M.D. 132 RelationshipsIndependent Director, Chairman of Science Committee and Member of Compensation Committee
MNTA Compensation vs. Industry
621.0K
359.1K
Chief Executive Officer
362.5K
262.7K
Chief Financial Officer
Share price activity for MOMENTA PHARMACEUTICALS INC (MNTA)
52 Week Price Performance
MNTA
Industry Average

Nominating Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 54 RelationshipsChairman, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteePeter Barton Hutt to Retire from Momenta Pharmaceuticals Inc.'s Board of Directors, Effective December 31, 2014
12/15/14
Marsha Fanucci 61 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeMomenta Pharmaceuticals Inc. Appoints Michael Franken as President, Biosimilars Business
12/12/13
Elizabeth Stoner M.D., M.S. 53 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Science CommitteeMomenta Pharmaceuticals Inc. Appoints Nic G. Scalfarotto, D.V.M. as Vice President of Regulatory Affairs
05/12/11

Corporate Governance Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
Marsha Fanucci 61 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Elizabeth Stoner M.D., M.S. 53 RelationshipsDirector, Member of Compensation Committee and Member of Science Committee
James Sulat MBA 54 RelationshipsIndependent Director, Chairman of Science Committee and Member of Compensation Committee
MNTA and Competitor
Insiders vs. External
Board
5%
95%
Momenta Pharmaceuticals Inc.
Insiders
External Board Members

Advisory Committee* - momenta pharmaceuticals inc (MNTA)

Name (Board Relationships)/Title Board Affiliations
Elliott Antman 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
K. Austen 59 Relationships
Member of Scientific Advisory Board
No other board affiliations
Carolyn Bertozzi 39 Relationships
Member of Scientific Advisory Board
No other board affiliations
Eugene Braunwald 41 Relationships
Member of Scientific Advisory Board
No other board affiliations
Francis Bullock 62 Relationships
Member of Scientific Advisory Board
No other board affiliations
Benito Casu 38 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Cooper 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
J. Crout 21 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Thomas Garvey 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Robert Pollock 32 Relationships
Member of Regulatory Advisory Board
No other board affiliations
William Reardon 55 Relationships
Advisor to Audit Committee
No other board affiliations
Phillips Robbins 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $10.77 USD -0.16

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MNTA.
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.